ECM
TSVT

ExodusPoint Capital Management’s 2seventy bio TSVT Stock Holding History

ExodusPoint Capital Management’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-25,161
Closed -$97K – 2108
2024
Q2 		$97K Buy
+25,161
New +$113K ﹤0.01% 1429
2023
Q4 		– Sell
-1,389,953
Closed -$5.45M – 2062
2023
Q3 		$5.45M Sell
1,389,953
-67,437
-5% -$442K 0.05% 353
2023
Q2 		$14.7M Buy
1,457,390
+428,350
+42% +$4.54M 0.12% 167
2023
Q1 		$10.5M Buy
1,029,040
+121,905
+13% +$1.39M 0.09% 266
2022
Q4 		$8.5M Buy
907,135
+662,390
+271% +$9.34M 0.12% 210
2022
Q3 		$3.56M Sell
244,745
-25,134
-9% -$373K 0.05% 526
2022
Q2 		$3.56M Buy
269,879
+36,294
+16% +$495K 0.04% 529
2022
Q1 		$3.98M Buy
233,585
+104,699
+81% +$1.78M 0.05% 468
2021
Q4 		$3.3M Buy
+128,886
New +$4.02M 0.03% 573

Other funds holding TSVT

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

ExodusPoint Capital Management's TSVT Position: Q3 2024 in Review

ExodusPoint Capital Management sold out of 2seventy bio (TSVT) in Q3 2024, closing a stake of 25,161 shares — an estimated $97K sold.

ExodusPoint Capital Management first reported a position in TSVT in Q4 2021 and held it in 9 quarters. The position peaked at $14.7M in Q2 2023. 115 funds tracked by Wall St. Rank hold TSVT as of Q3 2024.

  • ExodusPoint Capital Management reported no remaining 2seventy bio position as of Q3 2024 after selling out during the quarter.
  • ExodusPoint Capital Management sold 25,161 2seventy bio shares in Q3 2024, an estimated $97K.
  • ExodusPoint Capital Management first reported a position in 2seventy bio in Q4 2021 and held it in 9 quarters.
  • ExodusPoint Capital Management's 2seventy bio position peaked at $14.7M in Q2 2023.
  • 115 funds tracked by Wall St. Rank held 2seventy bio as of Q3 2024.

Based on ExodusPoint Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.